Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) EV-to-FCF : 8.88 (As of Jun. 23, 2024)

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-FCF Chart

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
EV-to-FCF	Get a 7-Day Free Trial						24.64	20.60	25.51	14.81	13.50

Competitive Comparison of Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF falls into.

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-FCF Calculation

Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF for today is calculated as:

Macro Group Pharmaceuticals (Macro Capital) Co's current Enterprise Value is E£1,119.9 Mil.
Macro Group Pharmaceuticals (Macro Capital) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£126.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macro Group Pharmaceuticals (Macro Capital) Co  (CAI:MCRO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Macro Group Pharmaceuticals (Macro Capital) Co's PE Ratio for today is calculated as:

Macro Group Pharmaceuticals (Macro Capital) Co's share price for today is E£2.01.
Macro Group Pharmaceuticals (Macro Capital) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Business Description